Cytokinetics, Incorporated is a company in the U.S. stock market and it is a holding in 62 U.S.-traded ETFs. CYTK has around 13.7M shares in the U.S. ETF market. The largest ETF holder of CYTK is the iShares Core S&P Small-Cap ETF (IJR), with approximately 4.73M shares. Investors may also find of interest that the ETF with the largest allocation to CYTK stock is Invesco S&P SmallCap Health Care ETF (PSCH), with a portfolio weight of 1.58%. On average, U.S. ETFs allocate 0.20% of CYTK to their portfolios.
Additionally, CYTK is a favorite stock for Vanilla and Growth ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with CYTK as a holding is the iShares Morningstar Small-Cap ETF (ISCB), with a return of 592.66%.